Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Cardiovascular: early-phase trial registry

6 of 9 indexed Cardiovascular trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

9 US clinical trials · 6 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cardiovascular: 9 US clinical trials tracked, 6 recruiting.

Cardiovascular is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Stratum Nutrition, running 1 of these trials.

Enrollment posture brief

Registry condition cardiovascular

OPEN 6 | RECR 67% | LATE 1 | EARLY 2 | RANK #1916 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Cardiovascular (this)67%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Cardiovascular

Cardiovascular lists 6 open slots (67% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiovascular on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiovascular is recruiting above its size-band peers.

    6 of 9 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Cardiovascular trials is spread across many organizations.

    Stratum Nutrition accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cardiovascular enrolment sits around 100 participants.

    Median target enrolment is 100 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Cardiovascular research is mostly interventional.

    7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1

Top Sponsors

Stratum Nutrition 1 trials
USRC Kidney Research 1 trials
Brijesh Patel 1 trials
Kessler Foundation 1 trials
Arizona State University 1 trials
Washington University School of Medicine 1 trials
Weill Medical College of Cornell University 1 trials
M.D. Anderson Cancer Center 1 trials
AstraZeneca 1 trials

Named interventions

Most-linked intervention names on Cardiovascular records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ferric Citrate 1 GM Oral Tablet [AURYXIA] Drug
1 trials
Low Dose Chitin-Glucan + Olive Extract Dietary supplement
1 trials
Low Dose Chitin-Glucan Dietary supplement
1 trials
Chitin-Glucan Dietary supplement
1 trials
AZD1705 Drug
1 trials
Quercetin (dietary supplement) Dietary supplement
1 trials
Risk managment Behavioral
1 trials
Washout - week 5 Other
1 trials

US sites by state

Facility locations filed on Cardiovascular trials. A trial with sites in several states counts in each.

Texas 3 trials
New York 2 trials
New Jersey 2 trials
Missouri 2 trials
Indiana 2 trials
Florida 2 trials
California 2 trials
Tennessee 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Cardiovascular page

9 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiovascular condition card totals 9 registered trials; most-linked intervention Ferric Citrate 1 GM Oral Tablet [AURYXIA]; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.